Candel Therapeutics

Candel Therapeutics

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-200
-149
-163
EBITDA
-22,781
-37,159
-7,148
-27,917
EBIT
-22,981
-37,330
-7,297
-28,080
Net Income
-21,873
-38,905
-8,861
-29,496
Net Change In Cash
0
0
0
0
Free Cash Flow
-23,260
-17,251
-18,712
-10,977
Cash
203,116
201,565
194,834
119,731
Basic Shares
77,385
74,131
62,361
54,898

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$0
$0
$31
$125
Gross Profit
-845
-990
-23,980
125
EBITDA
-35,218
-52,097
-34,384
-16,308
EBIT
-36,063
-53,087
-35,344
-17,086
Net Income
-38,182
-55,177
-37,939
-18,794
Net Change In Cash
0
0
31
125
Free Cash Flow
-38,898
-27,039
-34,701
-32,716
Cash
119,731
102,654
35,413
70,058
Basic Shares
52,958
31,675
28,935
28,823

Earnings Calls

QuarterEPS
2026-09-30
-$0.28
2026-06-30
-$0.35
2026-03-31
-$0.14
2025-12-31
-$0.29